Login to Your Account


‘PUTAMEN' THE SLAMMER, PHASE IB

Voyager Therapeutics Inc. has a Parkinson’s disease gene therapy that could last “essentially for as long as the patient lives, but at least 15 or 20 years,” CEO Steven Paul told BioWorld Today, commenting on phase Ib results with VY-AADC01.

more »


Our Habitat for All Things Science
Nobel Prize goes for autophagy research

"Basically, it's not easy to define what will serve humanity."

So said Yoshinori Ohsumi, honorary professor at the Tokyo Institute of Technology, after winning the 2012 Kyoto Prize in Life Sciences for his research.

The Nobel Assembly followed suit in recognizing the importance of Ohsumi's work, awarding him the 2016 Nobel Prize in Physiology or Medicine to "for his discoveries of mechanisms for autophagy."

READ MORE »

Opinion


Partners in Focus